StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Updates

<< Previous

Bullboard Posts

Next >>

Post by LithLoveron Sep 07, 2021 10:23am

303 Views

Post# 33818535

Updates

Health Clinic shares are now added into total

$33.4 M
Market cap

78.59 M
Shares

and new CFO has updated his LinkedIn with his starting last week.

Stagezero to present at next week's investor conference.

H.C. Wainwright 23rd Annual Global Investment Conference
September 13-15, 2021

https://hcwevents.com/annualconference/

Financial dates: Q3 will be Nov 15. Q4 will factor into audited year end which is March 31.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal